Literature DB >> 3546136

Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages.

L D Sibley, S G Franzblau, J L Krahenbuhl.   

Abstract

Mycobacterium leprae replicates within mononuclear phagocytes, reaching enormous numbers in the macrophage-rich granulomas of lepromatous leprosy. To examine the capability of macrophages to digest M. leprae, we studied the intracellular fate of M. leprae organisms in normal and activated mouse macrophages by using the electron-dense secondary lysosome tracer Thoria Sol. Intracellular M. leprae organisms, surrounded by a characteristic electron-transparent zone, were contained within phagosomal vacuoles of macrophages cultured in vitro for 1 to 6 days. In normal macrophages, a majority of phagosomes containing freshly isolated live M. leprae cells resisted fusion with Thoria Sol-labeled lysosomes. The extent of fusion was not significantly affected by pretreatment of M. leprae with human patient serum high in specific immunoglobulin G and M antibodies. In contrast, a majority of phagosomes containing gamma-irradiated M. leprae cells underwent lysosome fusion in normal macrophages. In addition, increased phagolysosome fusion was observed with live M. leprae-containing phagosomes in macrophages activated with gamma interferon. Increased fusion was associated with an increase in the number of fragmented and damaged bacilli, suggesting that increased digestion followed fusion. This study indicates that activated macrophages may have an increased capacity for clearance of normally resistant M. leprae.

Entities:  

Mesh:

Year:  1987        PMID: 3546136      PMCID: PMC260393          DOI: 10.1128/iai.55.3.680-685.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

Authors:  C F Nathan; G Kaplan; W R Levis; A Nusrat; M D Witmer; S A Sherwin; C K Job; C R Horowitz; R M Steinman; Z A Cohn
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

2.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

3.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

4.  Lysosomal activity of macrophages in leprosy.

Authors:  C K Job
Journal:  Arch Pathol       Date:  1970-12

5.  Electron-transparent zone of mycobacteria may be a defence mechanism.

Authors:  P Draper; R J Rees
Journal:  Nature       Date:  1970-11-28       Impact factor: 49.962

6.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  Early response of mouse foot pads to Mycobacterium laprae.

Authors:  M J Evans; H E Newton; L Levy
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

8.  Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria.

Authors:  P D Hart; J A Armstrong; C A Brown; P Draper
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae.

Authors:  M J Evans; L Levy
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

10.  The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  41 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Intramacrophage growth of Mycobacterium avium during infection of mice.

Authors:  C Frehel; C de Chastellier; C Offredo; P Berche
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

Review 4.  Acid resistance in Mycobacterium tuberculosis.

Authors:  Omar H Vandal; Carl F Nathan; Sabine Ehrt
Journal:  J Bacteriol       Date:  2009-05-22       Impact factor: 3.490

Review 5.  On guard: coronin proteins in innate and adaptive immunity.

Authors:  Jean Pieters; Philipp Müller; Rajesh Jayachandran
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

Review 6.  Why intracellular parasitism need not be a degrading experience for Mycobacterium.

Authors:  D G Russell; S Sturgill-Koszycki; T Vanheyningen; H Collins; U E Schaible
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

7.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

8.  Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

9.  In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.

Authors:  N Ramasesh; J L Krahenbuhl; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

10.  Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice.

Authors:  C de Chastellier; C Fréhel; C Offredo; E Skamene
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.